Pluri Inc. Deferred Tax Assets, Operating Loss Carryforwards, Foreign
Pluri Inc. (PLUR) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $35.17 million as of 2020-06-30, per its 10-K filed 2020-09-10.
Discontinued › Notes › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2020-09-10
- 2020-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $35.17M.
- 2019-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $40.87M.
- 2018-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $33.54M.
- 2017-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $26.27M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign |
|---|---|
| 2020-06-30 | $35.17M 10-K · filed 2020-09-10 |
| 2019-06-30 | $40.87M 10-K · filed 2020-09-10 |
| 2018-06-30 | $33.54M 10-K · filed 2019-09-12 |
| 2017-06-30 | $26.27M 10-K · filed 2018-09-12 |
| 2016-06-30 | $22.11M 10-K · filed 2017-09-07 |
| 2015-06-30 | $19.88M 10-K · filed 2016-09-07 |
| 2014-06-30 | $12.81M 10-K · filed 2015-09-09 |
| 2013-06-30 | $8.54M 10-K · filed 2014-09-11 |
| 2012-06-30 | $5.17M 10-K · filed 2013-09-11 |
| 2011-06-30 | $4.56M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |